<verdict>MOSTLY REALISTIC</verdict>
<score>8</score>
<lean>BALANCED</lean>
<lean_reasoning>
Most failures and successes follow their rolls. Four things leaned in the player's favour:
- DeepSeek V5 stayed in preview after Threat 5 missed.
- Action 3 picked up extras on its large margin (the CISA citation and Lloyd's contacts forwarding the mapping).
- The confirmation run was completed cleanly.

These are offset by harsh outcomes in Action 4 on a roll of 02: the lost appeal, an almost total casework shortfall, and zero outputs.
</lean_reasoning>
<reasoning>
The odds are well calibrated.
- Actions 1 and 2 at 45–50% suit ambitious research and publication in earnings week.
- Action 3 at 30% suits mostly routine engineering.
- Threat 3 at 85% correctly reflects how long healthcare vendor onboarding takes.
- Threat 5 at 30% is defensible as a two-part event, though it is at the low end given DeepSeek's real preview-to-GA gap of 2–3 weeks.

Action 1's failure is sensibly placed in the ambitious parts: the overseer variant failed screening on a plausible trade-off (spoofed acceptance cut to +1%, but refusal of legitimate corrections up 9% and throughput down 7%), contractor onboarding stalled, and the reconstruction intervention was never resourced. The routine confirmation run completes because Threat 1 did not materialise. The resulting CI narrowing, from 1–12 at 71% of episodes to 1–10 at full sample, is statistically plausible.

Action 2 at margin 22 gives a publication that is six days late and trimmed, with replication deferred under *Buist*. The Threat 2 nulls on Llama and Gemma are handled honestly, and the reactions from OpenAI engineers and Apollo are proportionate.

Action 5 fails for the reason flagged in the odds, the roughly three-week GC pre-clearance, while the routine KYC filing still goes through. That is good handling of a bundled action.

The capability step from 4.4 to 4.6 is explained (Akamai capacity, longer-horizon RL, GPT-6.2), and it fits the stated path to L5 by late 2027. The three exogenous events are mixed in sign and plausible.
</reasoning>
<issues>
- **Threat 5 branch choice.** It was a two-part threat (GA and notable misuse). Non-materialisation only rules out both happening together. Given DeepSeek's release cadence, GA without a headline misuse report was at least as likely as staying in preview. Choosing "still preview, rumoured September" is the more benign branch and was not justified.
- **Action 4 on a roll of 02.**
  - Losing the June appeal (the window closed two days before review) is a severe, irreversible harm to a household. It rests on a deadline that was never in the world state.
  - The cause chain (ring-fencing needed CSO sign-off bundled into Action 1) is a reasonable shared cause for the casework. It does not explain why the Q2 ledger was missing from the renewal, which the player explicitly allowed to go in incomplete.
  - This is slightly harsh on the routine parts.
- **Action 3 margin 68.** CISA citing the scaffold tests and Lloyd's contacts widely forwarding the mapping go beyond what was attempted. They are small but unrequested boosts.
- **Missing reaction to Q2 earnings.** Earnings dominated the month's framing, yet there are no results and no market or analyst reaction to Anthropic's margins or the allocation decision.
- **Trust scorecard.** It cites "local notice of B's lapse" before the lapse, which falls on 30 September. The timing is inconsistent.
</issues>
<feedback_for_simulator>
- When a two-part threat fails to materialise, say which part failed and choose the branch by its own likelihood. For DeepSeek V5 in September, GA should now be the default expectation unless you give a reason against it.
- Do not introduce new hard deadlines, such as appeal windows, inside a failure outcome unless they were in the prior world state or you flag them as newly discovered facts. Irreversible household harm needs a traceable cause.
- Report the Q2 earnings outcome and the market reaction, and carry the margin pressure into the Q4 allocation request.
- On large success margins, keep extras to what the player actually attempted. Extra endorsements from third parties should be their own plausible events, not bonuses from the margin.
</feedback_for_simulator>

<du_progress>
A. Verified technical alignment: 2/10 (0). Evidence: the full-sample confirmation is a small honesty effect, 5% (CI 1–10), and is now adequately powered. It is still internal, and the published code has not yet been independently replicated. Cross-family transfer was null on both Llama and Gemma, which suggests the effect may be bound to Claude's evaluator or training stack. The overseer-authentication variant failed screening.
B. Real-world alignment in action: 3/10 (0). Evidence: the nulls were published within nine days, and the release said explicitly that METR neither replicated nor endorsed the work. Failed experiments and the spoofed-correction finding were disclosed. On the worker side, a household lost its appeal route through program failure.
C. Human alignment: 2/10 (0). Evidence: OpenAI engineers publicly dismissed the effect as "evaluator-bound", and no lab adopted the recipe. The House staffer is lukewarm and replication is deferred under *Buist*. OpenAI's use of voluntary CAISI access is a minor positive.
D. Self-repairing systems: 5/10 (0). Evidence: preregistered screening criteria blocked a flawed candidate, and nulls were disclosed quickly. Both frameworks now integrate configuration checks, and the insurer has issued a concrete incident-data specification. Nothing was yet caught and fixed on live consequential systems.
E. Capability growth without trouble: 1/10 (0). Evidence: the index rose to 4.6 and OpenAI reports a 3.4:1 agent research ratio. An AI-assisted PyPI attack hit about 4,000 organisations, ransomware continues, and DeepSeek V5 GA is looming.
F. Robust governance and verification: 4/10 (0). Evidence: the KYC comment period has closed with the rule still live, and OpenAI used EO voluntary access for GPT-6.2. H.R. 9363 sets only a voluntary $20M baseline. The testing-institution text is stalled at GC, and AISI is still unfunded.
G. Broad benefit and no permanent underclass: 1/10 (0). Evidence: new-graduate unemployment is 7.0% and a top-five bank is cutting 6% of back-office staff. B's funding is lapsing, an appeal was lost, the ETPL tool failed QA, and no outputs reached users.
H. Diversity, agency and consent: 3/10 (0). Evidence: the frontier remains plural and containment tooling is open and vendor-neutral. Proliferation is uncontrolled and the CEO override is unchanged.
Overall: 26.5/100 (0)
Trajectory: FLAT. Biggest gain: the full-sample confirmation plus honest, fast publication of the nulls, and both frameworks adopting the configuration checks (A, B and D, within the same scores). Biggest backslide: the cross-family null undercutting the portability of Anthropic's alignment result, together with the worker-program failures (A and G, within the same scores).
</du_progress>

<setup_fix>
**Two-part threats have no resolution rule.**
- **What is wrong:** When a threat requires several conditions at once (for example "V5 GA and notable misuse") and does not materialise, nothing says which conditions failed.
- **What it causes:** The simulator can silently choose the most benign branch, as it did with DeepSeek V5 this month. I cannot tell whether that was a realistic draw or leniency.
- **Proposed change:** Either split two-part threats into separate rolls, or require the simulator to state its per-condition probabilities in message 1, so the branch taken on non-materialisation can be checked.

I also endorse the simulator's proposed rule for conditional approvals.
</setup_fix>
